HealthSouth Corp. (NYSE:HLS) had its target price lifted by Susquehanna from $37.00 to $40.00 in a research note released on Wednesday morning, American Banking and Market News reports. They currently have a positive rating on the stock.
Shares of HealthSouth Corp. (NYSE:HLS) traded down 0.18% on Wednesday, hitting $34.20. The stock had a trading volume of 218,020 shares. HealthSouth Corp. has a 1-year low of $20.43 and a 1-year high of $37.01. The stock has a 50-day moving average of $35.18 and a 200-day moving average of $32.29. The company has a market cap of $2.990 billion and a P/E ratio of 10.81.
HealthSouth Corp. (NYSE:HLS) last announced its earnings results on Tuesday, October 29th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.18. The company had revenue of $564.00 million for the quarter, compared to the consensus estimate of $557.50 million. During the same quarter in the previous year, the company posted $0.44 earnings per share. The company’s revenue for the quarter was up 5.0% on a year-over-year basis. On average, analysts predict that HealthSouth Corp. will post $1.89 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 2.10%. The ex-dividend date is Monday, December 30th.
In other HealthSouth Corp. news, COO Mark Tarr sold 11,000 shares of HealthSouth Corp. stock on the open market in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $35.27, for a total value of $387,970.00. Following the sale, the chief operating officer now directly owns 192,822 shares in the company, valued at approximately $6,800,832. The sale was disclosed in a filing with the SEC, which is available at this link.
HLS has been the subject of a number of other recent research reports. Analysts at RBC Capital raised their price target on shares of HealthSouth Corp. from $34.00 to $37.00 in a research note to investors on Wednesday, October 30th. They now have an outperform rating on the stock. Separately, analysts at Mizuho raised their price target on shares of HealthSouth Corp. from $39.00 to $42.00 in a research note to investors on Wednesday, October 30th. They now have a buy rating on the stock. Finally, analysts at Deutsche Bank raised their price target on shares of HealthSouth Corp. from $33.00 to $36.00 in a research note to investors on Wednesday, October 30th. They now have a hold rating on the stock. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has a consensus rating of Buy and an average target price of $37.36.
HealthSouth Corporation (NYSE:HLS) is an owner and operator of inpatient rehabilitation hospitals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.